Macrogenics (MGNX) Interest Expenses (2023 - 2026)
Macrogenics (MGNX) reported Interest Expenses of $4.9 million for Q1 2026, up 5272.53% year-over-year from $91000.0 in Q1 2025, and up 14.44% quarter-over-quarter from $4.3 million in Q4 2025.
Macrogenics (MGNX) Interest Expenses (2023 - 2026) Analysis & Trends
Macrogenics (MGNX) has 4 years of Interest Expenses data on file, last reported at $4.9 million in Q1 2026.
- Interest Expenses for Q1 2026 came in at $4.9 million, up 5272.53% year-over-year; the trailing twelve-month figure through Mar 2026 was $13.3 million (up 18126.03% YoY), and the FY2025 annual result was $8.5 million, up 663.05% from the prior year.
- Interest Expenses climbed to $4.9 million in Q1 2026 per MGNX's latest filing, from $4.3 million in the prior quarter.
- Over five years, Interest Expenses peaked at $4.9 million in Q1 2026 and troughed at -$24000.0 in Q4 2024.
- A 4-year average of $1.6 million and a median of $788000.0 in 2023 frame the typical range for Interest Expenses.
- The sharpest annual moves came in 2024 and 2025: Interest Expenses sank 99.22% in 2024, then jumped 17900.0% in 2025.
- A 4-year view of Interest Expenses shows it stood at $774000.0 in 2023, then slumped by 103.1% to -$24000.0 in 2024, then jumped by 17900.0% to $4.3 million in 2025, then grew by 14.44% to $4.9 million in 2026.
- Business Quant data shows MGNX's Interest Expenses at $4.9 million in Q1 2026, $4.3 million in Q4 2025, and $3.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -332,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 61,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -5.58 Mn |
| 10 | Macrogenics | 260.14 Mn | 193.63 Mn | - | 4.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.89 Mn |
| Mar 31, 2026 | 4.89 Mn |
| Dec 31, 2025 | 4.27 Mn |
| Dec 31, 2025 | 4.27 Mn |
| Sep 30, 2025 | 3.34 Mn |
| Sep 30, 2025 | 3.34 Mn |
| Jun 30, 2025 | 802,000.00 |
| Jun 30, 2025 | 802,000.00 |
| Mar 31, 2025 | 91,000.00 |
| Mar 31, 2025 | 91,000.00 |
| Dec 31, 2024 | -24,000.00 |
| Dec 31, 2024 | -24,000.00 |
| Jun 30, 2024 | 6,000.00 |
| Jun 30, 2024 | 6,000.00 |
| Mar 31, 2024 | 1.13 Mn |
| Mar 31, 2024 | 1.13 Mn |
| Jun 30, 2023 | 774,000.00 |
| Jun 30, 2023 | 774,000.00 |
| Mar 31, 2023 | 656,000.00 |
| Mar 31, 2023 | 656,000.00 |